LexDanaLexDanabeta
Inventor

DALE ANDO

Inventor
US

Overview

3→
Patents
2023–2024
Patent span
Chemistry
Primary field (CPC C)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides20%
C12NMicroorganisms or enzymes20%
A61KPreparations for medical, dental or toiletry purposes13%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7%
C12YEnzymes7%
PatentTitleYear
11,884,930Method of inactivating a glucocorticoid receptor gene in an isolated cell202411,857,641Method for the treatment of mucopolysaccharidosis type I202411,648,267Methods and compositions for gene inactivation2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2024Patents assigned to SANGAMO THERAPEUTICS INC (3)· patent assignee history
2023–2024Based in US· patent location history
2024Patents assigned to HOPE CITY (1)· patent assignee history
2024Patents assigned to SANGAMO BIOSCIENCES INC (1)· patent assignee history
2024Patents assigned to SANTANA ROSELIA C (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SANGAMO THERAPEUTICS INC32023–2024
HOPE CITY12024
SANGAMO BIOSCIENCES INC12024
SANTANA ROSELIA C12024
Locations
LocationPatentsSpan
US32023–2024